Normal Function
The AMH gene provides instructions for making a protein that is involved in male sex differentiation. During development of male fetuses, the AMH protein is produced and released (secreted) by cells of the testes. The secreted protein attaches (binds) to its receptor, which is found on the surface of Müllerian duct cells. The Müllerian duct, found in both male and female fetuses, is the precursor to the female reproductive organs. Binding of the AMH protein to its receptor induces self-destruction (apoptosis) of the Müllerian duct cells. As a result, the Müllerian duct breaks down (regresses) in males. In females, who do not produce the AMH protein during fetal development, the Müllerian duct becomes the uterus and fallopian tubes.
Health Conditions Related to Genetic Changes
Persistent Müllerian duct syndrome
Persistent Müllerian duct syndrome type 1, a disorder of sexual development that affects males, is caused by mutations in the AMH gene. Males with this condition have female reproductive organs in addition to normal male reproductive organs. At least 38 mutations in the AMH gene have been identified in people with persistent Müllerian duct syndrome type 1. Most mutations change single protein building blocks (amino acids) in the AMH protein. Other mutations result in a premature stop signal that leads to an abnormally short protein. Still other mutations delete regions of DNA from the AMH gene, which changes the instructions for the protein.
The mutated AMH protein cannot be released from the cells of the testes or cannot bind to the receptor on the Müllerian duct cells. As a result, the Müllerian duct cells never receive the signal for apoptosis. The Müllerian duct persists and becomes a uterus and fallopian tubes. Because the AMH protein is not involved in the formation of male reproductive organs, affected males also have male reproductive organs.
More About This Health ConditionOther Names for This Gene
- anti-Muellerian hormone
- MIF
- MIS
- muellerian-inhibiting factor
- muellerian-inhibiting substance
- Mullerian inhibiting factor
- Mullerian inhibiting substance
Additional Information & Resources
Tests Listed in the Genetic Testing Registry
Scientific Articles on PubMed
Catalog of Genes and Diseases from OMIM
References
- Belville C, Van Vlijmen H, Ehrenfels C, Pepinsky B, Rezaie AR, Picard JY, Josso N, di Clemente N, Cate RL. Mutations of the anti-mullerian hormone gene in patients with persistent mullerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model. Mol Endocrinol. 2004 Mar;18(3):708-21. doi: 10.1210/me.2003-0358. Epub 2003 Dec 12. Citation on PubMed
- Josso N, Belville C, di Clemente N, Picard JY. AMH and AMH receptor defects in persistent Mullerian duct syndrome. Hum Reprod Update. 2005 Jul-Aug;11(4):351-6. doi: 10.1093/humupd/dmi014. Epub 2005 May 5. Citation on PubMed
- Josso N, Picard JY, Imbeaud S, di Clemente N, Rey R. Clinical aspects and molecular genetics of the persistent mullerian duct syndrome. Clin Endocrinol (Oxf). 1997 Aug;47(2):137-44. doi: 10.1046/j.1365-2265.1997.2411044.x. No abstract available. Citation on PubMed
- Rey R. Anti-Mullerian hormone in disorders of sex determination and differentiation. Arq Bras Endocrinol Metabol. 2005 Feb;49(1):26-36. doi: 10.1590/s0004-27302005000100005. Epub 2006 Mar 16. Citation on PubMed
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.